In this report we present laboratory-based data for all GIT molecular panels requested for patients at PathCare laboratories for the last quarter (October to December 2024).
Graphs and data will be presented to highight the leading bacterial, viral and parasitic causes of diarrhoea during this period.
In this report we will also discuss the broad indications for molecular testing and antibiotic use in patients who present with gastroenteritis. Molecular testing now provides a platform to provide directed therapy timeously. Judicious use of antibiotics in the clinical setting has proven to be a critical antimicrobial stewardship tool.
Gastrointestinal (GIT) Pathogen Statistics